FutureDx Summit 2026 · Pharma & Biotech in AMR
Your Antimicrobial Needs a Diagnostic. Find It Here.
For pharma and biotech in AMR, a new antimicrobial only reaches the right patients when it is paired with the right diagnostic. FutureDx Summit 2026 is where you meet both the diagnostic partners and the clinical community that get it used.
P.S. Antibiotics, antifungals, or novel mechanisms, if its value depends on reaching the right infection, your ecosystem is here.
Instant download. Your PDF opens as soon as you submit.
The logic
In AMR, the Drug and the Diagnostic Travel Together
Stewardship restricts broad use, so the antimicrobials that win are the ones that can prove who needs them. That takes a diagnostic.
Stewardship Demands Targeting
Broad use is restricted, so you must identify the right patients.
Resistance Must Be Proven
A diagnostic shows your drug is the right answer for this infection.
Diagnostics Protect the Value
Guided use defends both the patient and the drug’s lifespan.
Who is in the room
Two Audiences, One Summit
AMR pharma comes for the partnerships and stays for the clinical access. FutureDx gives you both at once.
Diagnostic Partners
The companies building the rapid tests, panels, and companion diagnostics you could pair with your therapeutic.
The Clinical and Lab Community
The microbiologists, ID consultants, stewardship leads, and lab directors who determine how your drug is used.
The opportunities
Where Pharma and Diagnostics Connect
Six ways AMR therapeutics and diagnostics come together, all live conversations in the room.
Companion Diagnostics
Pair a test with your therapeutic.
Diagnostic-Guided Therapy
Get the right drug to the right infection.
Stewardship Alignment
Fit antibiotic strategy, do not fight it.
Rapid AST Pairing
Susceptibility results that trigger your drug.
Biomarker and Trial Partnerships
Diagnostics for stratification and trials.
Real-World Evidence
Data partnerships that prove impact.
The room
The Diagnostic and Clinical Ecosystem, Concentrated
The partners and prescribers an AMR therapeutic depends on, gathered in one validated room.
Delegate Seniority
Partners and Prescribers in the Same Place
For an AMR therapeutic, the diagnostics companies you might partner with and the clinicians who shape real-world use rarely sit in one room. Here they do, all validated before they register. Reach the ones you want with the 1:1 meetings programme.
How to take part
Three Ways to Engage
Whether you are here to partner, to build profile, or to lead the science, there is a route that fits.
1:1 Partner Meetings
Pre-arranged meetings with the partners and clinicians you choose.
See 1:1 MeetingsQuestions
Pharma and Biotech in AMR, Answered
Why would a pharma or biotech company sponsor a diagnostics summit?
Because in AMR, a therapeutic and a diagnostic increasingly travel together. A new antimicrobial reaches the right patients, and survives stewardship, when it is paired with a diagnostic that identifies who needs it. FutureDx puts the diagnostic partners and the clinical community who decide how your drug is used in one room.
Who will we actually meet?
Two groups. The diagnostics companies building the rapid tests, panels, and companion diagnostics you could pair with, and the clinical and lab community, consultant microbiologists, ID consultants, antimicrobial stewardship leads, and lab directors, who determine real-world use of your therapeutic.
Is this about finding diagnostic partners or reaching prescribers?
Both. The room holds potential companion-diagnostic and co-development partners, and it holds the microbiologists and stewardship leads whose decisions shape how an antimicrobial is used. Most AMR pharma teams come for the partnerships and stay for the clinical access.
We work on antifungals and novel antibiotics. Is this relevant?
Yes. Any antimicrobial whose value depends on getting to the right resistant infection benefits from the diagnostic and stewardship ecosystem in the room, whether that is antibiotics, antifungals, or novel mechanisms.
How do we take part?
Through pre-arranged 1:1 meetings with the partners and clinicians you choose, a sponsorship package for brand presence plus meetings, or a thought leadership slot to present your AMR science. Download the Partnership Guide for the options and pricing.
It is the inaugural edition. Is it worth it?
The specialist format is well established at comparable infectious disease and diagnostics events, and FutureDx applies it to a deliberately small, senior, validated room. For AMR pharma it concentrates the diagnostic and clinical ecosystem you need in two days.
When and where is FutureDx Summit 2026 held?
FutureDx Summit 2026 runs across two days on 27 and 28 October 2026 in London, UK, with a drinks reception on Day 1.
Build the partnership
Pair Your Antimicrobial With the Right Diagnostic
Send your details and a senior member of the team replies with the audience, the partner opportunities, how to take part, and pricing.
- Diagnostic partners and the clinical community in one room
- Pre-arranged meetings with the people you choose
- A reply from a person, not an autoresponder
P.S. Selling an AMR diagnostic rather than a therapeutic? See the AMR diagnostics page or the full packages.